← Leaderboards
Barry E Bleske
University Of Michigan At Ann Arbor
$493,118
Attributed
$493,118
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $181.3K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$493,118 · 6
By mechanism
R21$356,812 · 1
M01$136,306 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Kenneth A Jamerson$2,889,933
- Zhe Han$13,414,348
- Ryan Douglas Baldridge$2,734,576
- Albert P Rocchini$632,670
- Sharon L Kardia$26,865,896
Others in their field
Top investigators on “Antihypercholesterolemic Agent”
- Ronald M Krauss · University Of Calif-Lawrenc Berkeley Lab$10,346,841
- Barry Davis · University Of Texas Hlth Sci Ctr Houston$6,259,000
- Beatrice A Golomb · University Of California San Diego$5,517,551
- Patricia F Coogan · Boston University Medical Campus$2,532,527
- Bruce M Psaty · University Of Washington$2,093,698
- James Kuang-Jan Liao · Brigham And Women'S Hospital$2,013,135
Research focus
Antihypercholesterolemic AgentHuman SubjectDrug Screening /EvaluationClinical ResearchEnzyme ActivityPharmacokineticsLaboratory MouseHeart FailurePathologic ProcessDisease /Disorder ModelCofactorCardiovascular Disorder ChemotherapyCardiovascular AgentsCarvedilolCalcium Transporting AtpaseAntidepressive AgentsAffectBlood PressureComputer Retrieval Of Information On Scientific Projects DatabaseBiomarkerDrug InteractionsDrug KineticsAngiospermsAtorvastatin
Grant awards (8)
PAROXETINE & SILDENAFIL ON PHARMACOKINETICS OF METOPROLOL, CARVEDILOL, & ATENOLO$35,249
M01 · FY2007 · RR · contact PI
PAROXETINE & SILDENAFIL ON PHARMACOKINETICS OF METOPROLOL, CARVEDILOL, & ATENOLO$71,024
M01 · FY2006 · RR · contact PI
Mechanisms of Hawthorn Action in Heart Failure$177,728
R21 · FY2005 · AT
PAROXETINE &SILDENAFIL ON PHARMACOKINETICS OF METOPROLOL, CARVEDILOL, &ATENOLO$3,602
M01 · FY2005 · RR
Mechanisms of Hawthorn Action in Heart Failure$179,084
R21 · FY2004 · AT
Effect of Atorvastatin on Endothelial Function and TNF-alpha in Heart Failure$26,431
M01 · FY2004 · RR
Effect of pravastatin and atorvastatin on coenzyme Q10$0
M01 · FY2002 · RR
Effect of pravastatin and atorvastatin on coenzyme Q10$0
M01 · FY2000 · RR